Xeris Biopharma Holdings (XERS) Return on Assets [ROA] (2021 - 2026)
Xeris Biopharma Holdings (XERS) posted Return on Assets [ROA] of -4.27% for Q2 2026, up 5.57 percentage points from -9.84% a year earlier but down 7.37 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Xeris Biopharma Holdings' Return on Assets [ROA] came in at 0.16%, up 17.14 percentage points from FY2024.
- Annual Return on Assets [ROA] has increased for four consecutive years, with a four-year change of +53.11 percentage points (FY2021 to FY2025).
- In prior years, Xeris Biopharma Holdings' Return on Assets [ROA] was -16.99% in FY2024 (+1.68 pp), -18.66% in FY2023 (+10.51 pp), -29.18% in FY2022 (+23.78 pp) and -52.95% in FY2021.
- Quarterly Return on Assets [ROA] has run from a low of -56.34% in Q4 2021 to a high of 3.10% in Q1 2026 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last seven quarters, with an average year-over-year change of +8.73 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2022, with a gain of 27.11 percentage points; the weakest was Q3 2024, with a drop of 0.51 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 3.10% (Q1 2026), 0.15% (Q4 2025) and -4.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn | -1.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.55% |
| Jun 30, 2026 | -4.27% |
| Mar 31, 2026 | 3.10% |
| Dec 31, 2025 | 0.15% |
| Sep 30, 2025 | -4.44% |
| Jun 30, 2025 | -9.84% |
| Mar 31, 2025 | -14.12% |
| Dec 31, 2024 | -17.03% |
| Sep 30, 2024 | -19.32% |
| Jun 30, 2024 | -17.81% |
| Mar 31, 2024 | -19.54% |
| Dec 31, 2023 | -19.14% |
| Sep 30, 2023 | -18.83% |
| Jun 30, 2023 | -21.98% |
| Mar 31, 2023 | -23.35% |
| Dec 31, 2022 | -29.23% |
| Sep 30, 2022 | -42.64% |
| Jun 30, 2022 | -41.67% |
| Mar 31, 2022 | -43.02% |
| Dec 31, 2021 | -56.36% |
API Access
Xeris Biopharma Holdings Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();